Published in Radiat Res on December 01, 2009
Low-field magnetic resonance imaging to visualize chronic and cycling hypoxia in tumor-bearing mice. Cancer Res (2010) 1.49
Imaging cycling tumor hypoxia. Cancer Res (2010) 1.32
Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels. Nat Commun (2012) 1.30
Colorectal carcinogenesis--update and perspectives. World J Gastroenterol (2014) 1.19
Antiangiogenic agent sunitinib transiently increases tumor oxygenation and suppresses cycling hypoxia. Cancer Res (2011) 1.19
Optical imaging of tumor hypoxia dynamics. J Biomed Opt (2011) 1.16
Mathematical model for radial expansion and conflation of intratumoral infectious centers predicts curative oncolytic virotherapy parameters. PLoS One (2013) 1.08
A therapeutic role for targeting c-Myc/Hif-1-dependent signaling pathways. Cell Cycle (2010) 1.07
Microenvironment and radiation therapy. Biomed Res Int (2012) 1.06
Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling. Respir Res (2011) 1.03
NADPH oxidase subunit 4-mediated reactive oxygen species contribute to cycling hypoxia-promoted tumor progression in glioblastoma multiforme. PLoS One (2011) 1.00
Use of the ODD-luciferase transgene for the non-invasive imaging of spontaneous tumors in mice. PLoS One (2011) 1.00
Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response. Br J Radiol (2014) 0.99
18F-EF5 PET imaging as an early response biomarker for the hypoxia-activated prodrug SN30000 combined with radiation treatment in a non-small cell lung cancer xenograft model. J Nucl Med (2013) 0.95
Inhibition of endothelial cell proliferation and tumor angiogenesis by up-regulating NDRG2 expression in breast cancer cells. PLoS One (2012) 0.94
Correlation between ¹⁸F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas. Eur J Nucl Med Mol Imaging (2014) 0.92
Oxygen levels do not determine radiation survival of breast cancer stem cells. PLoS One (2012) 0.92
Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1. Neuro Oncol (2012) 0.91
Transient decrease in tumor oxygenation after intravenous administration of pyruvate. Magn Reson Med (2011) 0.91
EPR oxygen imaging and hyperpolarized 13C MRI of pyruvate metabolism as noninvasive biomarkers of tumor treatment response to a glycolysis inhibitor 3-bromopyruvate. Magn Reson Med (2012) 0.90
Sickle erythrocytes target cytotoxics to hypoxic tumor microvessels and potentiate a tumoricidal response. PLoS One (2013) 0.89
Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumors. Anticancer Agents Med Chem (2011) 0.87
In vivo hyperspectral imaging of microvessel response to trastuzumab treatment in breast cancer xenografts. Biomed Opt Express (2014) 0.87
Hypoxia and metabolic adaptation of cancer cells. Oncogenesis (2016) 0.86
Single acquisition quantitative single-point electron paramagnetic resonance imaging. Magn Reson Med (2013) 0.86
Dose painting based on tumor uptake of Cu-ATSM and FDG: a comparative study. Radiat Oncol (2014) 0.85
Temporal expression of hypoxia-regulated genes is associated with early changes in redox status in irradiated lung. Free Radic Biol Med (2012) 0.85
Liver sinusoidal endothelial and biliary cell repopulation following irradiation and partial hepatectomy. World J Gastroenterol (2010) 0.84
Molecular biology: the key to personalised treatment in radiation oncology? Br J Radiol (2010) 0.84
Strategies To Assess Hypoxic/HIF-1-Active Cancer Cells for the Development of Innovative Radiation Therapy. Cancers (Basel) (2011) 0.84
Magnetic resonance imaging of the tumor microenvironment in radiotherapy: perfusion, hypoxia, and metabolism. Semin Radiat Oncol (2014) 0.83
Imaging tumor hypoxia to advance radiation oncology. Antioxid Redox Signal (2014) 0.83
Glucose-6-phosphatase is a key metabolic regulator of glioblastoma invasion. Mol Cancer Res (2014) 0.82
Correlation between CT perfusion parameters and microvessel density and vascular endothelial growth factor in adrenal tumors. PLoS One (2013) 0.82
Changes in the transcriptome of morula-stage bovine embryos caused by heat shock: relationship to developmental acquisition of thermotolerance. Reprod Biol Endocrinol (2013) 0.81
A microfluidic device to study cancer metastasis under chronic and intermittent hypoxia. Biomicrofluidics (2014) 0.80
Preliminary studies with a new hypoxia-selective cytotoxin, KS119W, in vitro and in vivo. Radiat Res (2012) 0.80
The investigation of tumoral angiogenesis with HIF-1 alpha and microvessel density in women with endometrium cancer. J Turk Ger Gynecol Assoc (2012) 0.79
A generic cycling hypoxia-derived prognostic gene signature: application to breast cancer profiling. Oncotarget (2014) 0.79
Lacking hypoxia-mediated downregulation of E-cadherin in cancers of the uterine cervix. Br J Cancer (2013) 0.79
BAG3 and HIF-1 α coexpression detected by immunohistochemistry correlated with prognosis in hepatocellular carcinoma after liver transplantation. Biomed Res Int (2014) 0.79
Aplidin as a potential adjunct to radiation therapy: in vitro studies. Int J Radiat Biol (2010) 0.79
Targeting lung cancer through inhibition of checkpoint kinases. Front Genet (2015) 0.79
Tumor Metabolism, the Ketogenic Diet and β-Hydroxybutyrate: Novel Approaches to Adjuvant Brain Tumor Therapy. Front Mol Neurosci (2016) 0.79
Sustained radiosensitization of hypoxic glioma cells after oxygen pretreatment in an animal model of glioblastoma and in vitro models of tumor hypoxia. PLoS One (2014) 0.78
Application of optical imaging and spectroscopy to radiation biology. Radiat Res (2012) 0.78
On the importance of prompt oxygen changes for hypofractionated radiation treatments. Phys Med Biol (2013) 0.78
PET with 62Cu-ATSM and 62Cu-PTSM is a useful imaging tool for hypoxia and perfusion in pulmonary lesions. AJR Am J Roentgenol (2013) 0.78
Tumor hypoxia and reoxygenation: the yin and yang for radiotherapy. Radiat Oncol J (2016) 0.78
Radiation Promptly Alters Cancer Live Cell Metabolic Fluxes: An In Vitro Demonstration. Radiat Res (2016) 0.78
Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity. J Transl Med (2016) 0.76
The prospective application of a hypoxic radiosensitizer, doranidazole to rat intracranial glioblastoma with blood brain barrier disruption. BMC Cancer (2013) 0.76
Measuring tumor cycling hypoxia and angiogenesis using a side-firing fiber optic probe. J Biophotonics (2012) 0.76
Anti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia. Int J Oncol (2015) 0.75
Potential role of the glycolytic oscillator in acute hypoxia in tumors. Phys Med Biol (2015) 0.75
Combining Optical Reporter Proteins with Different Half-lives to Detect Temporal Evolution of Hypoxia and Reoxygenation in Tumors. Neoplasia (2015) 0.75
Design of optimized hypoxia-activated prodrugs using pharmacokinetic/pharmacodynamic modeling. Front Oncol (2013) 0.75
Sickle Cells Abolish Melanoma Tumorigenesis in Hemoglobin SS Knockin Mice and Augment the Tumoricidal Effect of Oncolytic Virus In Vivo. Front Oncol (2016) 0.75
Qiliqiangxin protects against anoxic injury in cardiac microvascular endothelial cells via NRG-1/ErbB-PI3K/Akt/mTOR pathway. J Cell Mol Med (2017) 0.75
Non-invasive Imaging of Cycling Hypoxia in Head & Neck Cancer Using Intrinsic Susceptibility MRI. Clin Cancer Res (2017) 0.75
Transport of drugs from blood vessels to tumour tissue. Nat Rev Cancer (2017) 0.75
Accelerated electron paramagnetic resonance imaging using partial Fourier compressed sensing reconstruction. Magn Reson Imaging (2016) 0.75
Spectroscopic characterization of oral epithelial dysplasia and squamous cell carcinoma using multiphoton autofluorescence micro-spectroscopy. Lasers Surg Med (2017) 0.75
[(18)F]Fluoromisonidazole PET in rectal cancer. EJNMMI Res (2017) 0.75
Targeting HIF-1 for cancer therapy. Nat Rev Cancer (2003) 28.01
Upstream and downstream of mTOR. Genes Dev (2004) 21.61
Mechanisms of angiogenesis. Nature (1997) 18.04
The biology of vascular endothelial growth factor. Endocr Rev (1997) 13.70
A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol (1992) 11.03
Vascular endothelial growth factor (VEGF) and its receptors. FASEB J (1999) 10.09
Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell (2004) 6.99
Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med (1997) 6.86
General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A (1993) 6.77
Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. Mol Cell Biol (2002) 5.39
Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer (2008) 4.71
Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer (2008) 4.50
Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer (2008) 4.43
Heterozygous HIF-1alpha deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J Physiol (2006) 3.12
Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways. Nat Cell Biol (2008) 3.04
Imaging of phosphorescence: a novel method for measuring oxygen distribution in perfused tissue. Science (1988) 2.92
Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol (1979) 2.89
Intermittent blood flow in a murine tumor: radiobiological effects. Cancer Res (1987) 2.85
Detection and characterization of tumor hypoxia using pO2 histography. Antioxid Redox Signal (2007) 2.76
Eukaryotic initiation factor 2alpha-independent pathway of stress granule induction by the natural product pateamine A. J Biol Chem (2006) 2.67
Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis. Clin Cancer Res (2007) 2.40
Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Res (2001) 2.19
Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res (1996) 2.07
Mammalian target of rapamycin complex 1: signalling inputs, substrates and feedback mechanisms. Cell Signal (2009) 2.07
Induction of HIF-1alpha expression by intermittent hypoxia: involvement of NADPH oxidase, Ca2+ signaling, prolyl hydroxylases, and mTOR. J Cell Physiol (2008) 2.06
Measurement of absolute oxygen levels in cells and tissues using oxygen sensors and 2-nitroimidazole EF5. Methods Enzymol (2002) 1.94
Acute hypoxia in tumors: implications for modifiers of radiation effects. Int J Radiat Oncol Biol Phys (1986) 1.84
Analysis of oxygen transport to tumor tissue by microvascular networks. Int J Radiat Oncol Biol Phys (1993) 1.73
The use of fluorescent probes to identify regions of transient perfusion in murine tumors. Int J Radiat Oncol Biol Phys (1989) 1.71
Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors. Acta Oncol (1995) 1.66
Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer. Int J Radiat Oncol Biol Phys (2008) 1.64
Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies. Cancer Res (2006) 1.62
The pervasive presence of fluctuating oxygenation in tumors. Cancer Res (2008) 1.61
Intussusceptive microvascular growth in a human colon adenocarcinoma xenograft: a novel mechanism of tumor angiogenesis. Microvasc Res (1996) 1.43
Quantification of longitudinal tissue pO2 gradients in window chamber tumours: impact on tumour hypoxia. Br J Cancer (1999) 1.42
Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers. Radiat Res (2007) 1.42
Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma. Cancer Res (2004) 1.38
Microvascular studies on the origins of perfusion-limited hypoxia. Br J Cancer Suppl (1996) 1.38
Fourier analysis of fluctuations of oxygen tension and blood flow in R3230Ac tumors and muscle in rats. Am J Physiol (1999) 1.36
Direct demonstration of instabilities in oxygen concentrations within the extravascular compartment of an experimental tumor. Cancer Res (2006) 1.34
Tumor regrowth after irradiation; an experimental approach. Int J Radiat Biol Relat Stud Phys Chem Med (1979) 1.33
Observation of incipient tumor angiogenesis that is independent of hypoxia and hypoxia inducible factor-1 activation. Cancer Res (2005) 1.29
Cellular radiosensitivity and tumor radiation response in the EMT6 tumor cell system. Radiat Res (1973) 1.25
Tumor-dependent kinetics of partial pressure of oxygen fluctuations during air and oxygen breathing. Cancer Res (2004) 1.24
Physiological noise in murine solid tumours using T2*-weighted gradient-echo imaging: a marker of tumour acute hypoxia? Phys Med Biol (2004) 1.22
The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography. Int J Radiat Oncol Biol Phys (2008) 1.22
Measuring Tumor Hypoxia. Semin Radiat Oncol (1996) 1.22
Perivascular oxygen tensions in a transplantable mammary tumor growing in a dorsal flap window chamber. Radiat Res (1992) 1.21
Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours. Int J Radiat Biol (1999) 1.21
The potential role of intrinsic hypoxia markers as prognostic variables in cancer. Antioxid Redox Signal (2007) 1.20
Relationship of hypoxia to metastatic ability in rodent tumours. Br J Cancer (2001) 1.15
Studies of vascular patterns in living tumors with a transparent chamber inserted in hamster cheek pouch. J Natl Cancer Inst (1965) 1.15
Angioadaptation: keeping the vascular system in shape. News Physiol Sci (2002) 1.11
The role of vessel maturation and vessel functionality in spontaneous fluctuations of T2*-weighted GRE signal within tumors. NMR Biomed (2006) 1.09
Combined hyperspectral and spectral domain optical coherence tomography microscope for noninvasive hemodynamic imaging. Opt Lett (2009) 1.09
Quantitative analysis of microvascular structure and function in the amelanotic melanoma A-Mel-3. Cancer Res (1981) 1.09
Quantifying transient hypoxia in human tumor xenografts by flow cytometry. Cancer Res (2004) 1.06
Microregional fluctuations in perfusion within human tumours detected using laser Doppler flowmetry. Radiother Oncol (1996) 1.06
Fluctuations in tumor blood perfusion assessed by dynamic contrast-enhanced MRI. Magn Reson Med (2007) 1.03
Temporal heterogeneity in oxygen tension in human melanoma xenografts. Br J Cancer (2003) 1.01
Exploring the role of HIF-1 in early angiogenesis and response to radiotherapy. Radiother Oncol (2007) 1.01
Fluctuations in pO2 in poorly and well-oxygenated spontaneous canine tumors before and during fractionated radiation therapy. Radiother Oncol (2005) 0.99
Orally administered pimonidazole to label hypoxic tumor cells. Cancer Res (2002) 0.98
Spectral imaging facilitates visualization and measurements of unstable and abnormal microvascular oxygen transport in tumors. J Biomed Opt (2008) 0.97
Increased expression of metastasis-related genes in hypoxic cells sorted from cervical and lymph nodal xenograft tumors. Lab Invest (2009) 0.95
2H-nuclear magnetic resonance imaging of tumor blood flow: spatial and temporal heterogeneity in a tissue-isolated mammary adenocarcinoma. Cancer Res (1992) 0.94
Tumor-line specific pO(2) fluctuations in human melanoma xenografts. Int J Radiat Oncol Biol Phys (2004) 0.91
Fluctuations in microvascular blood flow parameters caused by hemodynamic mechanisms. Am J Physiol (1994) 0.90
The effect of flunarizine on erythrocyte suspension viscosity under conditions of extreme hypoxia, low pH, and lactate treatment. Br J Cancer (1993) 0.88
Development of the vascular system in the hamster malignant neurilemmoma. Microvasc Res (1973) 0.84
Non-constant tumour blood flow--implications for therapy. Acta Oncol (2001) 0.83
Short-cycle hypoxia in the intact heart: hypoxia-inducible factor 1alpha signaling and the relationship to injury threshold. Am J Physiol Heart Circ Physiol (2006) 0.81
Analysis of the effects of exposure to acute hypoxia on oxidative lesions and tumour progression in a transgenic mouse breast cancer model. BMC Cancer (2008) 0.81
Progression and metastasis in a transgenic mouse breast cancer model: effects of exposure to in vivo hypoxia. Cancer Lett (2009) 0.78
Thymidine analogues to assess microperfusion in human tumors. Int J Radiat Oncol Biol Phys (2005) 0.77